Cargando…

Prevalence and risk factors for atrial fibrillation in a semi-rural sub-Saharan African population: The hEart oF ethiopia: Focus on Atrial Fibrillation (TEFF-AF) Study

BACKGROUND: There is a scarcity of reported data on the prevalence of atrial fibrillation (AF) in sub-Saharan Africa. OBJECTIVES: To undertake AF screening in semi-rural Ethiopia. METHODS: The TEFF-AF (The hEart oF Ethiopia: Focus on Atrial Fibrillation) study conducted AF screening using a single-l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pitman, Bradley M., Chew, Sok-Hui, Wong, Christopher X., Jaghoori, Amenah, Iwai, Shinsuke, Lyrtzis, Ellen, Lim, Matthew, Chew, Rebekah R.-X., Chew, Andrew, Sanders, Prashanthan, Lau, Dennis H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795290/ https://www.ncbi.nlm.nih.gov/pubmed/36589000 http://dx.doi.org/10.1016/j.hroo.2022.09.008

Ejemplares similares

Performance of a Mobile Single-Lead Electrocardiogram Technology for Atrial Fibrillation Screening in a Semirural African Population: Insights From “The Heart of Ethiopia: Focus on Atrial Fibrillation” (TEFF-AF) Study
por: Pitman, Bradley M, et al.
Publicado: (2021)

Atrial fibrillation in sub-Saharan Africa: The knowns and unknowns?
por: Linz, Dominik, et al.
Publicado: (2019)

Assessment of available online educational resources for patients with atrial fibrillation
por: Middeldorp, Melissa E., et al.
Publicado: (2022)

Anemia and iron deficiency in patients with atrial fibrillation
por: Hanna-Rivero, Nicole, et al.
Publicado: (2022)

Atrial fibrillation virtual ward: reshaping the future of AF care
por: Kotb, A, et al.
Publicado: (2022)

Indonesian registry on atrial fibrillation (OneAF)
por: Raharjo, Sunu Budhi, et al.
Publicado: (2021)

Half-eart /
por: Wilson, Edward O.

Pulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial
por: Verma, Atul, et al.
Publicado: (2023)

Information Theory and Atrial Fibrillation (AF): A Review
por: Dharmaprani, Dhani, et al.
Publicado: (2018)

Rationale and design of the IRON-AF study: a double-blind, randomised, placebo-controlled study to assess the effect of intravenous ferric carboxymaltose in patients with atrial fibrillation and iron deficiency
por: Tu, Samuel J, et al.
Publicado: (2021)

Left atrial, pulmonary vein, and left atrial appendage anatomy in Indigenous individuals: Implications for atrial fibrillation
por: Clarke, Nicholas A.R., et al.
Publicado: (2021)

Cardiorespiratory fitness, obesity and left atrial function in patients with atrial fibrillation
por: Mishima, Ricardo S., et al.
Publicado: (2022)

RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers
por: Crijns, Harry JGM, et al.
Publicado: (2012)

Inflammation, atrial fibrillation, and the potential role for colchicine therapy
por: Varghese, Bibin, et al.
Publicado: (2021)

Use of Oral Anticoagulants in Patients with Atrial Fibrillation: Preliminary Data from the Italian Atrial Fibrillation (ITALY-AF) Registry
por: Angeli, Fabio, et al.
Publicado: (2023)

Hospitalizations in patients with atrial fibrillation: an analysis from ROCKET AF
por: DeVore, Adam D., et al.
Publicado: (2016)

Atrial fibrillation and heart failure- results of the CASTLE-AF trial
por: Shah, Syed Raza, et al.
Publicado: (2018)

Atrial Fibrillation (AF) in Endurance Athletes: a Complicated Affair
por: Stergiou, Dimitrios, et al.
Publicado: (2018)

Progression and regression in the left atrial substrate in patients with atrial fibrillation: the PROGRESS-AF study
por: Marcon, L, et al.
Publicado: (2023)

Epidemiological characteristics, management, and outcomes of atrial fibrillation in TUNISIA: Results from the National Tunisian Registry of Atrial Fibrillation (NATURE‐AF)
por: Ouali, Sana, et al.
Publicado: (2021)

Prediction of Successful Pharmacological Cardioversion in Acute Symptomatic Atrial Fibrillation: The Successful Intravenous Cardioversion for Atrial Fibrillation (SIC-AF) Score
por: Niederdöckl, Jan Daniel, et al.
Publicado: (2022)

Korean Atrial Fibrillation (AF) Network: Genetic Variants for AF Do Not Predict Ablation Success
por: Choi, Eue-Keun, et al.
Publicado: (2015)

The difference of burden of ectopic beats in different types of atrial fibrillation and the effect of atrial fibrillation type on stroke risk in a prospective cohort of patients with atrial fibrillation (CODE-AF registry)
por: Cho, Seunghoon, et al.
Publicado: (2020)

Continuous monitoring after atrial fibrillation ablation: the LINQ AF study
por: Wechselberger, Simon, et al.
Publicado: (2018)

Monitoring for AF: Identifying the Burden of Atrial Fibrillation and Assessing Post-Ablation
por: Passman, Rod S.
Publicado: (2017)

Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF
por: Kozieł, Monika, et al.
Publicado: (2021)

Spironolactone in Atrial Fibrillation With Preserved Cardiac Fraction: The IMPRESS‐AF Trial
por: Shantsila, Eduard, et al.
Publicado: (2020)

Aldosterone Antagonism in Atrial Fibrillation: Implications for AF‐Predominant HFpEF
por: Ho, Jennifer E.
Publicado: (2020)

Symptomatic and Asymptomatic Patients in the Polish Atrial Fibrillation (POL-AF) Registry
por: Kiliszek, Marek, et al.
Publicado: (2021)

Age-dependent risk for thromboembolism in atrial fibrillation: The Fushimi AF registry
por: Esato, Masahiro, et al.
Publicado: (2022)

Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry
por: Gorczyca, Iwona, et al.
Publicado: (2020)

Fine Fibrillatory Wave as a Risk Factor for Heart Failure Events in Patients With Atrial Fibrillation: The Fushimi Atrial Fibrillation (AF) Registry
por: Kawaji, Tetsuma, et al.
Publicado: (2022)

Effectiveness and Safety of DOACs in Atrial Fibrillation Patients Undergoing Catheter Ablation: Results from the China Atrial Fibrillation (China-AF) Registry
por: Dong, Zhimin, et al.
Publicado: (2022)

Effects of Prevalent and Incident Chronic Kidney Disease on Cardiovascular Events in Patients with Atrial Fibrillation
por: Lin, Hsuan-Yu, et al.
Publicado: (2019)

In-Hospital Mortality Among Critically Ill Patients With Atrial Fibrillation (AF) Versus Patients Without AF
por: Mehreen, Tooba, et al.
Publicado: (2021)

Catheter Ablation of Atrial Fibrillation in U.S. Community Practice—Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
por: Holmqvist, Fredrik, et al.
Publicado: (2015)

The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF): Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands
por: ten Cate, V., et al.
Publicado: (2016)

Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT‐AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry
por: Fudim, Marat, et al.
Publicado: (2018)

Characteristics and Treatment of Atrial Fibrillation with Respect to the Presence or Absence of Heart Failure. Insights from the Multicenter Polish Atrial Fibrillation (POL-AF) Registry
por: Gawałko, Monika, et al.
Publicado: (2021)

Correction to: Fine Fibrillatory Wave as a Risk Factor for Heart Failure Events in Patients With Atrial Fibrillation: The Fushimi Atrial Fibrillation (AF) Registry
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_efe8i8inr5qdocusj7ncoq2r0p